Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 7/20 | 0.34 |
| ▸ | SLC2A3 | P11169 | 7/20 | 0.34 |
| ▸ | SLC2A4 | P14672 | 7/20 | 0.34 |
| ▸ | SLC2A2 | P11168 | 3/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13085168 | 0.91 | SLC2A1 (0.35) | SLC2A1SLC2A3SLC2A4SLC2A2RIPK1 | |
| SCHEMBL13090837 | 0.90 | SLC2A1 (0.32) | SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL13085489 | 0.90 | SLC2A1 (0.35) | SLC2A1SLC2A3SLC2A4SLC2A2RIPK1 | |
| SCHEMBL13090544 | 0.89 | KMT2A (0.35) | RIPK1KMT2AMEN1KLKB1TSHR | |
| SCHEMBL13090582 | 0.85 | SLC2A1 (0.32) | SLC2A1SLC2A3SLC2A4SLC2A2KMT2A | |
| SCHEMBL13085566 | 0.83 | AR (0.32) | SLC2A1SLC2A3SLC2A4SLC2A2MAPT | |
| SCHEMBL13085456 | 0.82 | SLC2A1 (0.36) | SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL16405131 | 0.82 | SLC2A1 (0.33) | SLC2A1SLC2A3SLC2A4SLC2A2KMT2A | |
| SCHEMBL10083881 | 0.82 | SLC2A1 (0.35) | SLC2A1SLC2A3SLC2A4SLC2A2KMT2A | |
| SCHEMBL13085327 | 0.82 | SLC2A1 (0.33) | SLC2A1SLC2A3SLC2A4SLC2A2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8324390-B2 | Tetrazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2012-12-04 | — | — | US | disclosed |
| US-20100256195-A1 | Tetrazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256195-A1 | Tetrazole-substituted anthranilamides as pesticides | ANTXR2, PNISR, H1-5 | SLC2A1 2324/4885SLC2A3 2023/4885SLC2A4 2344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.